on May 5, 2005
Published online before print May 5, 2005, doi: 10.1161/01.ATV.0000168909.44877.a7
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 3, 2004
Accepted on April 21, 2005
Genetic Determinants of Cardiovascular Disease Risk in Familial Hypercholesterolemia
Angelique C.M. Jansen ;
From the Departments of Vascular Medicine (A.C.M.J., E.S.v.A.-C., J.C.D., J.J.P.K.) and Clinical Epidemiology and Biostatistics (M.W.T.T.), Academic Medical Center, University of Amsterdam, the Netherlands; and the Department of Human Genetics (S.C., M.R.F., J.L.), Roche Molecular Systems, Inc, Alameda, Calif.
* To whom correspondence should be addressed. E-mail: e.vandongen{at}amc.uva.nl.
Objective--To investigate the contribution of polymorphisms in multiple candidate genes to cardiovascular disease (CVD) risk in a large cohort of patients with heterozygous familial hypercholesterolemia (FH).
Methods and Results--We genotyped 1940 FH patients for 65 polymorphisms in 36 candidate genes. During 91.451 person-years, 643 (33.1%) patients had at least 1 cardiovascular event. Multifactorial Cox survival analysis revealed that the G20210A polymorphism in the prothrombin gene was strongly associated with a significantly increased CVD risk (GA versus GG; P<0.001).
Conclusions--In a large cohort of FH patients, we found that the G20210A polymorphism in the prothrombin gene is strongly associated with CVD risk. Our results constitute a step forward in the unraveling of the hereditary propensity toward CVD in FH and might lead to better risk stratification and hence to more tailored therapy for CVD prevention.
Key words: cardiovascular disease • genetics • hypercholesterolemia • risk factors
This article has been cited by other articles:
 |
|
 |
|
  L. Mascitelli, U. Ravnskov, F. Pezzetta, and M. R. Goldstein After the Failure of ENHANCEd Cholesterol Lowering in Familial Hypercholesterolemia, SEAS of Problems with Ezetimibe Angiology, February 1, 2009; 60(1): 127 - 128. [PDF]
|
|
|
|
 |
|
 U. Ravnskov and K. S. McCully Vulnerable Plaque Formation from Obstruction of Vasa Vasorum by Homocysteinylated and Oxidized Lipoprotein Aggregates Complexed with Microbial Remnants and LDL Autoantibodies Ann. Clin. Lab. Sci., January 1, 2009; 39(1): 3 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. van der Net, D. M. Oosterveer, J. Versmissen, J. C. Defesche, M. Yazdanpanah, B. E. Aouizerat, E. W. Steyerberg, M. J. Malloy, C. R. Pullinger, J. J.P. Kastelein, et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia Eur. Heart J., September 2, 2008; 29(18): 2195 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. van der Net, J. van Etten, M. Yazdanpanah, G. M. Dallinga-Thie, J. J.P. Kastelein, J. C. Defesche, R. P. Koopmans, E. W. Steyerberg, and E. J.G. Sijbrands Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia Eur. Heart J., June 1, 2008; 29(11): 1370 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sorensen, T. Ranheim, K. S. Bakken, T. P. Leren, and M. A. Kulseth Retention of Mutant Low Density Lipoprotein Receptor in Endoplasmic Reticulum (ER) Leads to ER Stress J. Biol. Chem., January 6, 2006; 281(1): 468 - 476. [Abstract] [Full Text] [PDF]
|
|